These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12577144)

  • 21. A service evaluation comparing CVVH an CVVHD in minimising circuit failure.
    Ede J; Dale A
    Nurs Crit Care; 2017 Jan; 22(1):52-57. PubMed ID: 26871268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of amphotericin B lipid complex in critically ill patients on continuous veno-venous haemofiltration.
    Bellmann R; Egger P; Djanani A; Wiedermann CJ
    Int J Antimicrob Agents; 2004 Jan; 23(1):80-3. PubMed ID: 14732318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of filtration volume of continuous venovenous hemofiltration in the treatment of patients with acute renal failure in intensive care units.
    Brause M; Neumann A; Schumacher T; Grabensee B; Heering P
    Crit Care Med; 2003 Mar; 31(3):841-6. PubMed ID: 12626994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Continuous veno-venous hemofiltration in acute renal insufficiency and heart failure].
    Tortorella G; Gonzi G; Zambrelli P; Cabassi A; Borghetti A; Fiaccadori E
    Cardiologia; 1997 Aug; 42(8):845-8. PubMed ID: 9312410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variables associated with circuit life span in critically ill patients undergoing continuous renal replacement therapy: a prospective observational study.
    Zhang Z; Ni H; Lu B
    ASAIO J; 2012; 58(1):46-50. PubMed ID: 22210650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency.
    La Manna G; Pancaldi L; Dalmastri V; Cuna V; Capecchi A; Comai G; Persici E; Bacchi G; Cianciolo G; Lombardi A; Marrozzini C; Colì L; Stefoni S
    In Vivo; 2008; 22(1):123-9. PubMed ID: 18396794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effects of dialysate and ultrafiltration flow rate on solute clearance during continuous renal replacement therapy].
    Gong D; Ji D; Xie H; Xu B; Liu Y; Li L
    Zhonghua Nei Ke Za Zhi; 2001 Mar; 40(3):183-6. PubMed ID: 11798577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial.
    Ronco C; Belomo R; Homel P; Brendolan A; Dan M; Piccinni P; La Greca G
    EDTNA ERCA J; 2002; Suppl 2():7-12. PubMed ID: 12371727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hemodynamic effects during sustained low-efficiency dialysis versus continuous veno-venous hemofiltration for uremic patients with brain hemorrhage: a crossover study.
    Wu VC; Huang TM; Shiao CC; Lai CF; Tsai PR; Wang WJ; Huang HY; Wang KC; Ko WJ; Wu KD;
    J Neurosurg; 2013 Nov; 119(5):1288-95. PubMed ID: 23706048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Continuous veno-venous haemofiltration in adult intensive therapy].
    Kluczewski G; Gierek D; Kaczmarska A; Cyzowski T; Dąbek J; Krzych L
    Anestezjol Intens Ter; 2011; 43(2):80-4. PubMed ID: 22011867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration.
    Jamal JA; Mat-Nor MB; Mohamad-Nor FS; Udy AA; Wallis SC; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Jan; 45(1):41-5. PubMed ID: 25455853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition.
    Bihorac A; Ross EA
    Am J Kidney Dis; 2005 Nov; 46(5):908-18. PubMed ID: 16253732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Continuous veno-venous hemofiltration in treatment of acute severe hyponatremia: a report of 6 cases].
    Ji DX; Gong DH; Xu B; Tao J; Ren B; Zhang YD; Liu Y; Hu WX; Li LS
    Zhonghua Nei Ke Za Zhi; 2003 Nov; 42(11):781-4. PubMed ID: 14636466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration.
    Maseda E; Grau S; Villagran MJ; Hernandez-Gancedo C; Lopez-Tofiño A; Roberts JA; Aguilar L; Luque S; Sevillano D; Gimenez MJ; Gilsanz F
    J Antimicrob Chemother; 2014 Jun; 69(6):1624-32. PubMed ID: 24505092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum IL-6 and IL-1-ra with sequential organ failure assessment scores in septic patients receiving high-volume haemofiltration and continuous venovenous haemofiltration.
    Ghani RA; Zainudin S; Ctkong N; Rahman AF; Wafa SR; Mohamad M; Manaf MR; Ismail R
    Nephrology (Carlton); 2006 Oct; 11(5):386-93. PubMed ID: 17014550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study.
    Joannidis M; Kountchev J; Rauchenzauner M; Schusterschitz N; Ulmer H; Mayr A; Bellmann R
    Intensive Care Med; 2007 Sep; 33(9):1571-9. PubMed ID: 17563874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of piperacillin in critically ill patients receiving continuous venovenous haemofiltration: A randomised controlled trial of continuous infusion versus intermittent bolus administration.
    Jamal JA; Roberts DM; Udy AA; Mat-Nor MB; Mohamad-Nor FS; Wallis SC; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2015 Jul; 46(1):39-44. PubMed ID: 25881872
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K; Jearnsujitwimol O; Susantitaphong P; Kijkriengkraikul N; Leelahavanichkul A; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of Fluoride as a Marker Solute to Quantify the Current Effective Delivered Dose in Continuous Renal Replacement Therapy: An "in vitro" Study.
    Villa G; Bocciero V; Neri M; Pomarè Montin D; Angeli E; Di Filippo A; Falsini S; Adembri C; De Gaudio AR; Romagnoli S
    Blood Purif; 2020; 49(6):685-691. PubMed ID: 32200385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutathione Reductase Is Associated with the Clinical Outcome of Septic Shock in the Patients Treated Using Continuous Veno-Venous Haemofiltration.
    Moisejevs G; Bormane E; Trumpika D; Baufale R; Busmane I; Voicehovska J; Grigane A; Suba O; Silova A; Skesters A; Lejnieks A; Gailite L; Brigis G
    Medicina (Kaunas); 2021 Jul; 57(7):. PubMed ID: 34356970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.